Sign In
Buy ILMN
$170.93
+8.38 (+5.16%)
At Close: Jun 03, 2026
Why Illumina Stock Got Mashed on Monday
05:12pm, Monday, 10'th Feb 2025
On Monday, for the second time in as many business days, Illumina (ILMN -5.47%) stock took it on the chin because of an analyst recommendation downgrade. The biotech's shares closed the day almost 6%
Illumina (ILMN) International Revenue Performance Explored
10:21am, Monday, 10'th Feb 2025
Review Illumina's (ILMN) international revenue performance and how it affects the predictions of financial analysts on Wall Street and the future prospects for the stock.
Illumina: Regulatory Risk In China And Weaker Sales Rebound Mask A Solid Rebound Of Its Profitability
07:17am, Monday, 10'th Feb 2025
Illumina restored its profitability well: Free Cash Flow is reaching elevated levels. However, the placement of ILMN in China's unreliable entity list could have disruptive implications for its operat
Cathie Wood Sours on Tesla and Moderna, but Likes These Stocks Instead
07:44am, Saturday, 08'th Feb 2025
Star portfolio manager Cathie Wood's Ark Investment Management filed its 13F holdings report for the fourth quarter on Feb.
Why Illumina Stock Is Sinking Today
03:03pm, Friday, 07'th Feb 2025
Shares of Illumina (ILMN -8.97%) were falling on Friday. The company's stock was down by as much as 11.4% early in the session, and was still off by 8.7% as of 2:38 p.m.
Illumina Analysts Slash Their Forecasts Following Q4 Results
02:22pm, Friday, 07'th Feb 2025
Illumina, Inc. ILMN reported better-than-expected results for its fourth quarter on Thursday.
ILMN Q4 Earnings Miss Estimates, Stock Dips in Aftermarket
10:16am, Friday, 07'th Feb 2025
Illumina's fourth-quarter revenues from the consumables business show robust growth.
Illumina, Inc. (ILMN) Q4 2024 Earnings Call Transcript
09:33pm, Thursday, 06'th Feb 2025
Illumina, Inc. (NASDAQ:ILMN ) Q4 2024 Earnings Conference Call February 6, 2025 4:30 PM ET Company Participants Salli Schwartz - Vice President of Investor Relations Jacob Thaysen - Chief Executive Of
Illumina (ILMN) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates
08:01pm, Thursday, 06'th Feb 2025
The headline numbers for Illumina (ILMN) give insight into how the company performed in the quarter ended December 2024, but it may be worthwhile to compare some of its key metrics to Wall Street esti
Illumina (ILMN) Q4 Earnings Miss Estimates
07:05pm, Thursday, 06'th Feb 2025
Illumina (ILMN) came out with quarterly earnings of $0.86 per share, missing the Zacks Consensus Estimate of $0.92 per share. This compares to earnings of $0.14 per share a year ago.
Illumina forecasts 2025 revenue largely below estimates
04:42pm, Thursday, 06'th Feb 2025
Gene sequencing machine maker Illumina forecast 2025 revenue largely below Wall Street estimates on Thursday, signaling subdued demand for its genetic tests and diagnostic tools, sending shares down n
Illumina Reports Financial Results for Fourth Quarter and Fiscal Year 2024
04:05pm, Thursday, 06'th Feb 2025
Core Illumina revenue of $1.1 billion for Q4 2024, up 1% from Q4 2023 on both a reported and constant currency basis; revenue of $4.3 billion for fiscal year 2024, down 2% from fiscal year 2023 on bot
Cathie Wood dumped Palantir to buy these biotech stocks
08:42am, Thursday, 06'th Feb 2025
Ark Invest Management chief executive officer (CEO) Cathie Wood is a lauded yet controversial figure.
Why Illumina Stock Plummeted Today
06:38pm, Tuesday, 04'th Feb 2025
Genomic sequencing specialist Illumina (ILMN -5.26%) was something of a victim in the U.S.-China trade spat on Tuesday. The government of the sprawling Asian nation placed the U.S. company on a blackl
China hits back at Trump's tariffs, targeting select U.S. imports
11:48am, Tuesday, 04'th Feb 2025
China countered President Donald Trump's across-the-board tariffs on Chinese products with tariffs on select U.S. imports Tuesday, as well as announcing an antitrust investigation into Google and othe
